# Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix

> **NCT00193739** · PHASE3 · UNKNOWN · sponsor: **Tata Memorial Hospital** · enrollment: 635 (actual)

## Conditions studied

- Cancer of Cervix

## Interventions

- **DRUG:** NACT
- **PROCEDURE:** Radical abdominal hysterectomy (class III), BPLND & lower para aortic lymph node sampling
- **DRUG:** Inj.Cisplatin
- **RADIATION:** Concurrent chemo radiotherapy

## Key facts

- **NCT ID:** NCT00193739
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-09-04
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 635 (ACTUAL)
- **Last updated:** 2019-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193739, "Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix". Retrieved via MORVS 2026-09-30 from https://api.morvs.ai/clinical/NCT00193739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*